Stage III Ovarian Epithelial Cancer Completed Phase 1 / 2 Trials for Ixabepilone (DB04845)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00182767Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian CancerTreatment